AtlasXomics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$14M
- Investors
-
7
AtlasXomics General Information
Description
Developer of a spatial epigenome technology platform designed to provide multi-omics tissue atlases. The company's platform leverages microfluidics and next-generation sequencing to create transformative multi-omic maps of proteomics, transcriptomics, and epigenomics in tissue at cellular resolution, enabling clinicians and researchers to unlock information about interactions between cells in localized neighborhoods.
Contact Information
Website
www.atlasxomics.comCorporate Office
- 101 College Street
- Suite 210
- New Haven, CT 06510
- United States
Corporate Office
- 101 College Street
- Suite 210
- New Haven, CT 06510
- United States
AtlasXomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series A) | 25-Jul-2024 | $14M | Completed | Generating Revenue | ||
| 4. Grant | 16-Sep-2022 | Completed | Generating Revenue | |||
| 3. Grant | 01-May-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 09-Mar-2021 | $2.26M | $2.26M | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2020 | Completed | Startup |
AtlasXomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed-2 | ||||||||
| Seed-1 | 1,461,538 | $0.001000 | 6% | $0.68 | $0.68 | 1x | $0.68 | 11.1% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
AtlasXomics Patents
AtlasXomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250146915-A1 | System for clamping and aligning a fluidic chip to a tissue section | Pending | 06-Jun-2023 | ||
| EP-4601792-A2 | Chiplet production and methods of use | Pending | 21-Nov-2022 | ||
| US-20260199893-A1 | Chiplet production and methods of use | Pending | 21-Nov-2022 | ||
| WO-2024112645-A2 | Chiplet production and methods of use | Inactive | 21-Nov-2022 | ||
| WO-2024112645-A3 | Chiplet production and methods of use | Inactive | 21-Nov-2022 | B01L3/502707 |
AtlasXomics Signals
AtlasXomics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Broadfield Capital | PE/Buyout | Minority | ||
| Connecticut Innovations | Venture Capital | Minority | ||
| Spring Mountain Capital | Growth/Expansion | Minority | ||
| U.S. Department of Health and Human Services | Government | |||
| National Institutes of Health | Government |
AtlasXomics FAQs
-
When was AtlasXomics founded?
AtlasXomics was founded in 2020.
-
Where is AtlasXomics headquartered?
AtlasXomics is headquartered in New Haven, CT.
-
What is the size of AtlasXomics?
AtlasXomics has 22 total employees.
-
What industry is AtlasXomics in?
AtlasXomics’s primary industry is Discovery Tools (Healthcare).
-
Is AtlasXomics a private or public company?
AtlasXomics is a Private company.
-
What is the current valuation of AtlasXomics?
The current valuation of AtlasXomics is .
-
What is AtlasXomics’s current revenue?
The current revenue for AtlasXomics is .
-
How much funding has AtlasXomics raised over time?
AtlasXomics has raised $16.3M.
-
Who are AtlasXomics’s investors?
Broadfield Capital, Connecticut Innovations, Spring Mountain Capital, U.S. Department of Health and Human Services, and National Institutes of Health are 5 of 7 investors who have invested in AtlasXomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process